Network testing discovery, packages & price visibility

Existing Network Catalog and Laboratories screens admit only canonical Core-published inventory. They offer discovery and request access, not direct network ordering. Categories come only from an exactly matching published health_category; free-text names and unreviewed suggestions do not create reviewed coverage.

• Reviewed published categories may include wellness, cardiometabolic, hormones, thyroid, nutrition, inflammation, infectious disease and home collection. Category membership grants no clinical equivalence or authorization.
• A future/nonorderable capability may appear only if separately authorized for public discovery; imported future/Live source status never publishes it.
• Unknown geography, specimen or collection serviceability remains unknown/nonorderable. Laboratory listing, paid readiness and item eligibility are separate facts.

1. Order an existing approved Program test/panel only through current canonical server authorization; public discovery alone cannot order.
2. Compose a buyer package only from already-authorized laboratory orderables. This grouping is not a new LIS native panel; same codes from different labs retain full tenant/lab/code identity.
3. Request a new panel/capability for laboratory review through existing saved draft/review workflows. A request is non-executable and cannot create a native orderable.

A network Program sees cross-lab supply only with exact active trusted per-lab grants. Public viewers receive only explicitly authorized public-safe published network price. Private network pricing is Quote required; DTC consumer price, laboratory-native cost, contracted Program price and network terms cannot substitute for public network price.

Paused/revoked Program, inactive/future/unreviewed offering, unknown serviceability, wrong tenant or missing published offering authorization fails closed for eligibility and price projections. Explicit lab-owner or buyer contracted-price visibility requires verified scope. Payment/subscription and Production gates remain independent.

Future R1 describes an originating/sending laboratory and separately approved performing laboratory using laboratory organization identity, source/destination native codes, versioned mapping, specimen/accession chain and distinct relationship/commercial scope. A consumer-health account is not a reference laboratory.